Carbamazepine
1
Reactions 479 - 27 Nov 1993 Carbamazepine Transient thrombocytopenia while continuing treatment: case report Thrombocytopenia developed in a 20-year-old woman after she received carbamazepine 400 mg/day for 2 weeks for behavioural and affective disturbances. One week later, despite toxic carbamazepine levels (14.2 µg/ml), the patient’s platelet count had normalised. Carbamazepine was discontinued and lithium introduced. The woman’s platelet count remained within normal range. Author comment: ‘This [case report] suggests that carbamazepine-induced thrombocytopenia may be transient in some patients.’ Terao T. Transient thrombocytopenia while continuing carbamazepine. American Journal of Psychiatry 150: 1750-1751, Nov 1993 - Japan 800224526 1 Reactions 27 Nov 1993 No. 479 0114-9954/10/0479-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved
Transcript of Carbamazepine
Reactions 479 - 27 Nov 1993
Carbamazepine
Transient thrombocytopenia while continuingtreatment: case report
Thrombocytopenia developed in a 20-year-old woman aftershe received carbamazepine 400 mg/day for 2 weeks forbehavioural and affective disturbances. One week later,despite toxic carbamazepine levels (14.2 µg/ml), the patient’splatelet count had normalised.
Carbamazepine was discontinued and lithium introduced.The woman’s platelet count remained within normal range.
Author comment: ‘This [case report] suggests thatcarbamazepine-induced thrombocytopenia may be transient insome patients.’Terao T. Transient thrombocytopenia while continuing carbamazepine. AmericanJournal of Psychiatry 150: 1750-1751, Nov 1993 - Japan 800224526
1
Reactions 27 Nov 1993 No. 4790114-9954/10/0479-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved
